Abstract:Objective To investigate the expression and clinical significance of long-chain non-coding RNA CCHE1 (lncRNA CCHE1) in hepatitis B virus infection-related liver cancer tissues. Methods The liver cancer tissues and adjacent tissues of 94 patients with hepatitis B virus infection-related liver cancer in Shaoxing Second Hospital from January 2012 to December 2014 were selected for research. Real-time quantitative polymerase chain reaction (RT-PCR) was used to determine the expression level of lncRNA CCHE1 in liver cancer tissues and adjacent tissues. Results The expression level of lncRNA CCHE1 in liver cancer tissue was higher than that in adjacent tissues (P < 0.05). There were no statistically significant difference in the expression levels of lncRNA CCHE1 in liver cancer tissues of patients of different ages, genders and degrees of alcoholism (P > 0.05). The lncRNA CCHE1 expression levels in patients with tumor diameter ≥ 5 cm, TNM stage III and IV cancer, portal vein tumor thrombus, and lymph node metastasis were higher than those in patients with tumor diameter < 5 cm, TNM stage I and Ⅱ cancer, no portal vein tumor thrombus, and no lymph node metastasis (P < 0.05). The area under the ROC curve for the diagnosis of liver cancer by lncRNA CCHE1 was 0.814 (95% CI: 0.811, 0.817), the sensitivity was 72.31% (95% CI: 0.693, 0.734), and the specificity was 79.24% (95% CI: 0.743, 0.831). The 5-year survival rate (46.81%) of patients with low expression in lncRNA CCHE1 was higher than that of patients with high expression in lncRNA CCHE1 (19.15%) (c2= 8.134, P = 0.004). Conclusions The expression level of lncRNA CCHE1 in hepatitis B virus infectionrelated liver cancer tissues is increased and is closely related to the clinicopathological characteristics, which is of certain value in disease diagnosis and prognosis evaluation.